Dharmacon Revenue and Competitors
Estimated Revenue & Valuation
- Dharmacon's estimated annual revenue is currently $2M per year.
- Dharmacon's estimated revenue per employee is $155,000
Employee Data
- Dharmacon has 13 Employees.
- Dharmacon grew their employee count by -19% last year.
Dharmacon's People
Name | Title | Email/Phone |
---|---|---|
1 | Manufacturing Engineer | Reveal Email/Phone |
2 | Customer Support | Reveal Email/Phone |
3 | Scientist I | Reveal Email/Phone |
4 | Scientist I | Reveal Email/Phone |
Dharmacon Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Dharmacon?
Dharmacon revolutionized the field of RNA synthesis in 1995 with the introduction of 2’-ACE synthesis chemistry and has been supporting the RNA and gene modulation research community for over 20 years. Dharmacon was an early participant in the RNA interference field and published key scientific contributions to the biological mechanism and research tool design and established market leadership with our siRNA platform. The acquisition of Open Biosystems strengthened our RNAi portfolio with genome-wide vector-based shRNA research tools. Today, our gene modulation research tools have expanded to include CRISPR-Cas9 gene editing reagents. We launched the very first synthetic CRISPR-Cas9 guide RNAs, and now offer one of the most comprehensive CRISPR gene editing portfolios in the industry, including the first arrayed synthetic CRISPR RNA whole human genome library. Our gene editing products include predesigned genome-wide lentiviral and synthetic guide RNA reagents designed by a validated algorithm, Cas9 nucleases, and design tools & kits for homology-directed repair. We have a well-established history of supporting the global genomics research community and we remain focused on the development and support of innovative, effective tools for the greater research community.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 13 | -24% | N/A |
#2 | $1.4M | 13 | N/A | N/A |
#3 | $1.1M | 13 | N/A | N/A |
#4 | $2.1M | 13 | N/A | N/A |
#5 | $1.4M | 13 | N/A | N/A |